[Home]  [Headlines]  [Latest Articles]  [Latest Comments]  [Post]  [Sign-in]  [Mail]  [Setup]  [Help] 

Status: Not Logged In; Sign In

A Missile Shield for America - A Trillion Dollar Fantasy?

Kentucky School Board Chairman Resigns After Calling for People to ‘Shoot Republicans’

These Are 2025's 'Most Livable' Cities

Nicotine and Fish

Genocide Summer Camp, And Other Notes From The Edge Of The Narrative Matrix

This Can Create Endless Green Energy WITHOUT Electricity

Geoengineering: Who’s Behind It and How We Stop It

Pam Bondi Ordered Prosecution of Dr. Kirk Moore After Refusing to Dismiss Case

California woman bombarded with Amazon packages for over a year

CVS ordered to pay $949 MILLION in Medicaid fraud case.

Starmer has signed up to the UNs agreement to raise taxes in the UK

Magic mushrooms may hold the secret to longevity: Psilocybin extends lifespan by 57% in groundbreaking study

Cops favorite AI tool automatically deletes evidence of when AI was used

Leftist Anti ICE Extremist OPENS FIRE On Cops, $50,000 REWARD For Shooter

With great power comes no accountability.

Auto loan debt hits $1.63T. 20% of buyers now pay $1,000+ monthly. Texas delinquency hits 7.92%.

Quotable Quotes from the Chosenites

Tokara Islands NOW crashing into the Ocean ! Mysterious Swarm continues with OVER 1700 Quakes !

Why Austria Is Suddenly Declaring War on Immigration

Rep. Greene Wants To Remove $500 Million in Military Aid for Nuclear-Armed Israel From NDAA

Netanyahu Lays Groundwork for Additional Strikes on Iran: 'We Didn't Deal With The Enriched Uranium'

Sweden Cracks Down On OnlyFans - Will U.S. Follow Suit?

Joe Rogan CALLS OUT Israel's Media CONTROL

Communist Billionaire Accused Of Funding Anti-ICE Riots Mysteriously Vanishes

6 Factors That Describe China's Current State

Trump Thteatens to Bomb Moscow and Beijing

Little Bitty

Vertiv Drops After Amazon Unveils In-House Liquid Cooling System, Marking Pivot To Liquid

17 Out-Of-Place Artifacts That Suggest High-Tech Civilizations Existed Thousands (Or Millions) Of Years Ago

Hamas Still Killing IDF Soldiers After 642 Days


Science/Tech
See other Science/Tech Articles

Title: Protein 'Switches' Could Turn Cancer Cells Into Tiny Chemotherapy Factories
Source: [None]
URL Source: http://www.sciencedaily.com/releases/2011/09/110923130110.htm
Published: Sep 25, 2011
Author: staff
Post Date: 2011-09-25 05:53:01 by Tatarewicz
Keywords: None
Views: 22

ScienceDaily (Sep. 24, 2011) — Johns Hopkins researchers have devised a protein "switch" that instructs cancer cells to produce their own anti-cancer medication.

In lab tests, the researchers showed that these switches, working from inside the cells, can activate a powerful cell-killing drug when the device detects a marker linked to cancer. The goal, the scientists said, is to deploy a new type of weapon that causes cancer cells to self-destruct while sparing healthy tissue.

This new cancer-fighting strategy and promising early lab test results were reported this week in the online early edition of Proceedings of the National Academy of Sciences. Although the switches have not yet been tested on human patients, and much more testing must be done, the researchers say they have taken a positive first step toward adding a novel weapon to the difficult task of treating cancer.

One key problem in fighting cancer is that broadly applied chemotherapy usually also harms healthy cells. In the protein switch strategy, however, a doctor would instead administer a "prodrug," meaning an inactive form of a cancer-fighting drug. Only when a cancer marker is present would the cellular switch turn this harmless prodrug into a potent form of chemotherapy.

"The switch in effect turns the cancer cell into a factory for producing the anti-cancer drug inside the cancer cell," said Marc Ostermeier, a Johns Hopkins chemical and biomolecular engineering professor in the Whiting School of Engineering, who supervised development of the switch.

"The healthy cells will also receive the prodrug," he added, "and ideally it will remain in its non-toxic form. Our hope is that this strategy will kill more cancer cells while decreasing the unfortunate side effects on healthy cells."

To demonstrate that these switches can work, the research team successfully tested them on human colon cancer and breast cancer cells in Ostermeier's lab and in the laboratory of James R. Eshleman, a professor of pathology and oncology in the Johns Hopkins School of Medicine.

"This is a radically different tool to attack cancers," said Eshleman, a co-author of the PNAS journal article, "but many experiments need to be done before we will be able to use it in patients."

The next step is animal testing, expected to begin within a year, Ostermeier said.

Ostermeier's team made the cancer-fighting switch by fusing together two different proteins. One protein detects a marker that cancer cells produce. The other protein, from yeast, can turn an inactive prodrug into a cancer-cell killer. "When the first part of the switch detects cancer, it tells its partner to activate the chemotherapy drug, destroying the cell," Ostermeier said.

In order for this switch to work, it must first get inside the cancer cells. Ostermeier said this can be done through a technique in which the switch gene is delivered inside the cell. The switch gene serves as the blueprint from which the cell's own machinery constructs the protein switch. Another approach, he said, would be to develop methods to deliver the switch protein itself to cells.

Once the switches are in place, the patient would receive the inactive chemotherapy drug, which would turn into a cancer attacker inside the cells where the switch has been flipped on.

Although many researchers are developing methods to deliver anti-cancer drugs specifically to cancer cells, Ostermeier said the protein switch tactic skirts difficulties encountered in those methods.

"The protein switch concept changes the game by providing a mechanism to target production of the anti-cancer drugs inside cancer cells instead of targeting delivery of the anti-cancer drug to cancer cells," he said.

Post Comment   Private Reply   Ignore Thread  



[Home]  [Headlines]  [Latest Articles]  [Latest Comments]  [Post]  [Sign-in]  [Mail]  [Setup]  [Help]